Table 12 Biological activities and predicted targets of oleocanthal, oleacein, luteolin, tyrosol, ezetimibe, and bempedoic acid via the PASS server and SwissTargetPrediction.

From: Chemical evaluation of arbequina extra virgin olive oil with in silico analysis of its key phenolic compounds targeting LDL metabolism

Drugs	Pa	Pi	Predicted Activity (PASS)	Predicted Target (SwissTargetPrediction)
Oleocanthal	0.774	0.042	Ubiquinol-cytochrome-c reductase inhibitor	Hepatocyte growth factor receptor
Oleocanthal	0.741	0.015	Protein-disulfide reductase (glutathione) inhibitor	Arachidonate 5-lipoxygenase
Oleocanthal	0.635	0.004	Aldose reductase substrate	Histone deacetylase 6
Oleocanthal	0.645	0.054	Polyporopepsin inhibitor	Histone deacetylase 2
Oleocanthal	0.622	0.035	GST A substrate	Histone deacetylase 8
Oleacein	0.761	0.005	Chemopreventive	Arachidonate 5-lipoxygenase
Oleacein	0.742	0.053	Ubiquinol-cytochrome-c reductase inhibitor	Hepatocyte growth factor receptor
Oleacein	0.664	0.026	Protein-disulfide reductase (glutathione) inhibitor	Histone deacetylase 6
Oleacein	0.647	0.027	Feruloyl esterase inhibitor	Histone deacetylase 8
Oleacein	0.626	0.019	Preneoplastic conditions treatment	Histone deacetylase 1
Luteolin	0.978	0.001	Chlordecone reductase inhibitor	NADPH oxidase 4
Luteolin	0.965	0.003	Membrane integrity agonist	Aldose reductase
Luteolin	0.964	0.003	HIF1A expression inhibitor	Cyclin-dependent kinase 5/CDK5 activator 1
Luteolin	0.953	0.002	Membrane permeability inhibitor	Xanthine dehydrogenase
Luteolin	0.952	0.002	2-Dehydropantoate 2-reductase inhibitor	Monoamine oxidase A
Tyrosol	0.928	0.004	Aspulvinone dimethylallyltransferase inhibitor	Carbonic anhydrase II
Tyrosol	0.922	0.003	Linoleate diol synthase inhibitor	Estrogen-related receptor gamma
Tyrosol	0.924	0.006	Membrane integrity agonist	GABA-A receptor; alpha-1/beta-2/gamma-2
Tyrosol	0.923	0.008	CYP2C12 substrate	Cyclooxygenase-1
Tyrosol	0.912	0.004	Chlordecone reductase inhibitor	Androgen Receptor
Ezetimibe	0.862	0.004	Atherosclerosis treatment	Cannabinoid receptor 1
Ezetimibe	0.845	0.004	Lipoprotein disorders treatment	Cannabinoid receptor 2
Ezetimibe	0.734	0.001	Niemann-Pick C1-like 1 protein antagonist	11-beta-hydroxysteroid dehydrogenase 1
Ezetimibe	0.698	0.014	Muramoyltetrapeptide carboxypeptidase inhibitor	Estrogen receptor alpha
Ezetimibe	0.684	0.015	Hypolipemic	Estrogen receptor beta
Bempedoic Acid	0.943	0.002	APOA1 expression enhancer	Peroxisome proliferator-activated receptor delta
Bempedoic Acid	0.943	0.003	Sphinganine kinase inhibitor	Peroxisome proliferator-activated receptor alpha
Bempedoic Acid	0.937	0.003	Lipid metabolism regulator	11-beta-hydroxysteroid dehydrogenase 1
Bempedoic Acid	0.926	0.003	Alkylacetylglycerophosphatase inhibitor	Free fatty acid receptor 1
Bempedoic Acid	0.925	0.003	Acylcarnitine hydrolase inhibitor	Solute carrier family 22 member 6 (by homology)

Back to article page

Table 12 Biological activities and predicted targets of oleocanthal, oleacein, luteolin, tyrosol, ezetimibe, and bempedoic acid via the PASS server and SwissTargetPrediction.

Search

Quick links